Works matching DE "BOOSTER vaccines"
Results: 2402
JN.1 variants circulating in Italy from October 2023 to April 2024: genetic diversity and immune recognition.
- Published in:
- BMC Infectious Diseases, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12879-025-10685-0
- By:
- Publication type:
- Article
Cellular immune breadth of an Omicron-specific, self-amplifying monovalent mRNA vaccine booster for COVID-19.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01076-2
- By:
- Publication type:
- Article
Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 192, doi. 10.3390/vaccines13020192
- By:
- Publication type:
- Article
Immunosuppressive Treatments and Risk Factors Associated with Non-Response to Hepatitis B Vaccination: A Cohort Study.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 184, doi. 10.3390/vaccines13020184
- By:
- Publication type:
- Article
The Humoral Immune Response Against COVID-19 Through Vaccination in Hemodialysis Patients.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 170, doi. 10.3390/vaccines13020170
- By:
- Publication type:
- Article
Effectiveness of Heterologous and Homologous Ad26.COV2.S Vaccine Boosting in Preventing COVID-19-Related Outcomes Among Individuals with a Completed Primary Vaccination Series in the United States.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 166, doi. 10.3390/vaccines13020166
- By:
- Publication type:
- Article
Immunogenicity of SARS-CoV-2 Vaccination Schedules Including a Booster Dose in Patients with Systemic Lupus Erythematosus: Data from a Prospective Multicenter Study.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 127, doi. 10.3390/vaccines13020127
- By:
- Publication type:
- Article
Immunosuppressive Therapy Modifies Anti-Spike IgG Subclasses Distribution After Four Doses of mRNA Vaccination in a Cohort of Kidney Transplant Recipients.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 123, doi. 10.3390/vaccines13020123
- By:
- Publication type:
- Article
Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 192, doi. 10.3390/vaccines13020192
- By:
- Publication type:
- Article
Immunosuppressive Treatments and Risk Factors Associated with Non-Response to Hepatitis B Vaccination: A Cohort Study.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 184, doi. 10.3390/vaccines13020184
- By:
- Publication type:
- Article
The Humoral Immune Response Against COVID-19 Through Vaccination in Hemodialysis Patients.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 170, doi. 10.3390/vaccines13020170
- By:
- Publication type:
- Article
Effectiveness of Heterologous and Homologous Ad26.COV2.S Vaccine Boosting in Preventing COVID-19-Related Outcomes Among Individuals with a Completed Primary Vaccination Series in the United States.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 166, doi. 10.3390/vaccines13020166
- By:
- Publication type:
- Article
Immunogenicity of SARS-CoV-2 Vaccination Schedules Including a Booster Dose in Patients with Systemic Lupus Erythematosus: Data from a Prospective Multicenter Study.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 127, doi. 10.3390/vaccines13020127
- By:
- Publication type:
- Article
Immunosuppressive Therapy Modifies Anti-Spike IgG Subclasses Distribution After Four Doses of mRNA Vaccination in a Cohort of Kidney Transplant Recipients.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 123, doi. 10.3390/vaccines13020123
- By:
- Publication type:
- Article
Editorial: Safety and Effectiveness of COVID-19 Vaccines on COVID-19 Infection and Its Long-Term Consequences.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
New onset of protein-losing enteropathy in a patient with Fontan circulation after COVID-19 vaccination: dread the cure or the disease?
- Published in:
- Cardiology in the Young, 2025, v. 35, n. 2, p. 418, doi. 10.1017/S1047951125000204
- By:
- Publication type:
- Article
Hepatitis B vaccine and juvenile idiopathic arthritis: comparison of the seropositivity rates with healthy children at the time of diagnosis and booster dose response under treatment.
- Published in:
- Clinical Rheumatology, 2025, v. 44, n. 3, p. 1299, doi. 10.1007/s10067-025-07313-2
- By:
- Publication type:
- Article
Evaluation of COVID-19 Booster Vaccine Effectiveness.
- Published in:
- Viruses (1999-4915), 2025, v. 17, n. 2, p. 179, doi. 10.3390/v17020179
- By:
- Publication type:
- Article
Amalgamation of ROAD-TGM and progressive PCA using performance booster method for detail persevering image denoising.
- Published in:
- Multimedia Tools & Applications, 2022, v. 81, n. 2, p. 1719, doi. 10.1007/s11042-021-11426-6
- By:
- Publication type:
- Article
Reduced early response to SARS‐CoV2 vaccination in people with type 1 and type 2 diabetes, a 6 months follow‐up study: The CoVaDiab study I.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2023, v. 39, n. 3, p. 1, doi. 10.1002/dmrr.3601
- By:
- Publication type:
- Article
Measles-mumps-rubella booster vaccination in juvenile idiopathic arthritis patients while receiving biological agents.
- Published in:
- Clinical Rheumatology, 2025, v. 44, n. 2, p. 867, doi. 10.1007/s10067-025-07318-x
- By:
- Publication type:
- Article
No evidence of short-term impact of repeated BNT162b2 vaccination on rheumatoid arthritis homeostasis in drug-free remission.
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 8, p. 2605, doi. 10.1007/s10067-022-06250-8
- By:
- Publication type:
- Article
Inactivated SARS-CoV-2 vaccine in primary Sjögren's syndrome: humoral response, safety, and effects on disease activity.
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 7, p. 2079, doi. 10.1007/s10067-022-06134-x
- By:
- Publication type:
- Article
New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword?
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Vaccination and Clinical Status in Patients Hospitalized for Covid-19 Infection in a Tertiary Hospital.
- Published in:
- Eurasian Journal of Medical Investigation, 2022, p. 50, doi. 10.14744/ejmi.2022.48180
- By:
- Publication type:
- Article
Factors related to adherence to public COVID-19 prevention behaviors, United States, April-July 2021.
- Published in:
- Population Medicine, 2022, v. 4, p. 1, doi. 10.18332/popmed/154850
- By:
- Publication type:
- Article
Immune Response and Histopathological Changes of Serratia rubidaea in Mice.
- Published in:
- Al-Anbar Journal of Veterinary Sciences, 2024, v. 17, n. 2, p. 17, doi. 10.37940/AJVS.2024.17.2.4
- By:
- Publication type:
- Article
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00708-9
- By:
- Publication type:
- Article
Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in children.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00702-1
- By:
- Publication type:
- Article
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00693-z
- By:
- Publication type:
- Article
Systematic review and meta-analysis of myocarditis and pericarditis in adolescents following COVID-19 BNT162b2 vaccination.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00681-3
- By:
- Publication type:
- Article
Evaluation of the immunization effectiveness of bOPV booster immunization and IPV revaccination.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00642-w
- By:
- Publication type:
- Article
Booster vaccination with Ad26.COV2.S or an Omicron-adapted vaccine in pre-immune hamsters protects against Omicron BA.2.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00633-x
- By:
- Publication type:
- Article
Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00580-z
- By:
- Publication type:
- Article
Anti-Ad26 humoral immunity does not compromise SARS-COV-2 neutralizing antibody responses following Gam-COVID-Vac booster vaccination.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00566-x
- By:
- Publication type:
- Article
Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00565-y
- By:
- Publication type:
- Article
Characterization of B-cell and T-cell responses to a tetravalent dengue purified inactivated vaccine in healthy adults.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00537-2
- By:
- Publication type:
- Article
Affordable SARS-CoV-2 protein vaccines for the pandemic endgame.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00507-8
- By:
- Publication type:
- Article
Author Correction: Antibody responses to the RTS,S/AS01<sub>E</sub> vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Comparative analysis of human immune responses following SARS-CoV-2 vaccination with BNT162b2, mRNA-1273, or Ad26.COV2.S.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00504-x
- By:
- Publication type:
- Article
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00459-z
- By:
- Publication type:
- Article
BCG-induced trained immunity enhances acellular pertussis vaccination responses in an explorative randomized clinical trial.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00438-4
- By:
- Publication type:
- Article
Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00434-8
- By:
- Publication type:
- Article
Extended interval BNT162b2 vaccination enhances peak antibody generation.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00432-w
- By:
- Publication type:
- Article
Revaccination with Bacille Calmette-Guérin (BCG) is associated with an increased risk of abscess and lymphadenopathy.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-021-00421-5
- By:
- Publication type:
- Article
Altered expression of miRNA profile in peripheral blood mononuclear cells following the third dose of inactivated COVID-19 vaccine.
- Published in:
- PeerJ, 2025, p. 1, doi. 10.7717/peerj.18856
- By:
- Publication type:
- Article
Self-reported side effects of COVID-19 vaccines among health professions students in India.
- Published in:
- PeerJ, 2024, p. 1, doi. 10.7717/peerj.17083
- By:
- Publication type:
- Article
Factors associated with intention to be vaccinated with the COVID-19 booster dose: a cross-sectional study in Peru.
- Published in:
- PeerJ, 2024, p. 1, doi. 10.7717/peerj.16727
- By:
- Publication type:
- Article
Seroprevalence of SARS-CoV-2 anti-spike IgG antibody among COVID-19 vaccinated individuals residing in Surabaya, East Java, Indonesia.
- Published in:
- PeerJ, 2023, p. 1, doi. 10.7717/peerj.16142
- By:
- Publication type:
- Article
REACTOGENICITY OF HETEROLOGOUS MRNA-BASED COVID-19 VACCINE BOOSTER IN YOUNG ADULTS IN INDONESIA- A SHORT COMMUNICATION.
- Published in:
- African Journal of Infectious Diseases, 2023, v. 17, n. 2, p. 9, doi. 10.21010/Ajidv17i2.2
- By:
- Publication type:
- Article